Racing Against Local Competitors: The Challenges of Vaccine Manufacturers Expanding into China
Powered by ![]()
All the vital news, analysis, and commentary curated by our industry experts.
$2995
Despite China being an attractive market with high unmet needs for vaccines, overseas manufacturers have reported that the sales growth of their imported vaccines has slowed last year. In this report, GlobalData explores recent trends in the Chinese vaccine market and reviews the challenges that overseas vaccine manufacturers may face when expanding their vaccine business frameworks to this emerging market.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
See what our customers are saying
Related reports
View more Vaccine reports
New
New
New